Analysis of PON1 gene polymorphisms (rs662 and rs854560) and inflammatory markers in organophosphate pesticides exposed cohorts from two distinct populations.

2020 ◽  
Vol 191 ◽  
pp. 110210
Author(s):  
Mbah Ntepe Leonel Javeres ◽  
Rabia Habib ◽  
Ngondi Judith ◽  
Moaz Iqbal ◽  
Eugenie Nepovimova ◽  
...  
2021 ◽  
Vol 17 (1) ◽  
pp. 119-126
Author(s):  
Charuta Godbole ◽  
Saket Thaker ◽  
Prafulla Kerkar ◽  
Milind Nadkar ◽  
Nithya Gogtay ◽  
...  

Background: The present case–control study evaluated the association of PON1 gene polymorphisms and enzyme activity in the western Indian population. Materials & methods: Angiographically proven coronary artery disease (CAD) formed the cases. PON1 polymorphisms (Q192R, L55M) and enzymatic activity (paraoxonase) were assessed. Results: A total of 502 participants (251 per group) were studied. PON1 Q192R and L55M polymorphisms were not associated with the risk of CAD. Notably, a weak association was observed between Q192R polymorphisms and the risk of CAD. CAD patients had significantly lower PON1 enzymatic activity (U/L) as compared with the controls regardless of the genotype. Conclusion: Low serum PON1 activity was confirmed to be an independent predictor for the risk of CAD.


2016 ◽  
Vol 29 (7) ◽  
pp. 379-388 ◽  
Author(s):  
Rosimar Neris Martins Feitosa ◽  
Antonio Carlos Rosário Vallinoto ◽  
Pedro Fernando da Costa Vasconcelos ◽  
Raimunda do Socorro da Silva Azevedo ◽  
Vânia Nakauth Azevedo ◽  
...  

2021 ◽  
Vol 102 (6) ◽  
pp. 805-814
Author(s):  
V A Kachnov ◽  
E V Kryukov ◽  
S N Kolyubaeva ◽  
G G Kutelev ◽  
V V Tyrenko

Aim. To study the frequency of polymorphisms in genes associated with lipid metabolism disorders in young people with risk of sudden cardiac death, to identify the relationships between gene polymorphisms and risk factors of sudden cardiac death, and to develop mathematical models to identify the probability of carrying mutations in these genes. Methods. The study included 436 young people (mean age 19.81.6 years). A standard examination and survey by questionnaire specially developed by us were conducted to identify an increased risk of sudden cardiac death. 59 individuals with a risk of sudden cardiac death were selected. The control group was 65 people, which was comparable to the study group. A blood test was performed to determine lipid profile and polymorphisms: Leu28Pro (rs 429358) in gene APOE, C3238G (rs 5128) in gene APOC3, Gln192Arg (rs 662) in gene PON1, Ser447Ter (rs 328) in gene LPL, G250A (rs 1800588) in gene LIPC. Statistical analysis was performed using the statistical package SPSS 17.0 and Statistica 6.0. The parametric KruskalWallis test, the MannWhitney U-test, the Pearsons chi-squared test, the Spearman rank correlation coefficient, and logistic regression analysis were used. Results. We revealed a high frequency of Gln192Arg (rs 662) polymorphism in the PON1 gene in the group of individuals at risk of sudden cardiac death and its correlation with the deaths in relatives under age 50 years. Mathematical models for predicting the presence of polymorphisms in genes associated with lipid metabolism disorders have been developed. Among the developed mathematical models, the models for identifying carriers of the minor allele of Gln192Arg polymorphism in the PON1 gene, Ser447Ter in the LPL gene, and 250 GA in the LIPC gene had the highest sensitivity, specificity, and accuracy. Conclusion. In persons at risk for sudden cardiac death, it is advisable to conduct a screening for mutations in genes associated with lipid metabolism disorders, especially in Gln192Arg polymorphism in gene PON1.


Sign in / Sign up

Export Citation Format

Share Document